The Filing Desk

argenx vs United Therapeutics

argenx ARGX · United Therapeutics UTHR · Biotechnology

argenx reported revenue of $4.2 billion in fiscal 2025, 1.3 times United Therapeutics' $3.2 billion in fiscal 2025. argenx's revenue grew 88.6% in its latest year, and United Therapeutics' grew 10.6%. argenx had an operating margin of 24.8%, against 46.9% at United Therapeutics. Free cash flow was $679 million at argenx and $1.0 billion at United Therapeutics.

Side by side

argenxUnited Therapeutics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$4.2B$3.2B
Revenue growth88.6%10.6%
Revenue growth a year, last 5 years152.7%16.5%
Gross margin89.4%87.9%
Operating margin24.8%46.9%
Net margin30.4%41.9%
Free cash flow$679M$1.0B
Free cash flow margin16.0%32.7%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$1.0B
Change in diluted share count1.3%−1.2%
Last close$942.04$559.10
P/E at the last close—21.1×
Insider trades, last 12 months—bought $863,940, sold $1.4 billion
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
argenxUnited Therapeutics
Operating margin
Percent of revenue
argenxUnited Therapeutics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
argenxUnited Therapeutics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the argenx and United Therapeutics pages.